Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Biguanides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 2 Insulin Resistance 2 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ketosis 1 Glioma 1 Glioblastoma 1 Diabetes Mellitus, Type 2 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 137 Bevacizumab 63 Radiotherapy 59 Magnetic Resonance Spectroscopy 58 Irinotecan 26 Surgical Procedures, Operative 22 Carboplatin 22 Radiation 19 Carmustine 18 Aminolevulinic Acid 18 Specimen Handling 17 Blood Specimen Collection 16 Nivolumab 15 Lomustine 15 Biopsy 15 pembrolizumab 13 Radiotherapy, Intensity-Modulated 12 trametinib 11 Radiosurgery 11 Cyclophosphamide 11 fluorodopa F 18 10 X-Rays 10 Topotecan 9 IL13-PE38 9 Everolimus 9 Erlotinib Hydrochloride 9 ribociclib 8 dabrafenib 8 Surveys and Questionnaires 8 Imatinib Mesylate 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02149459 2017-10-27

SMC 0712-13

Sheba Medical Center

Phase 1 Unknown

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Insulin Resistance, Ketosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡